July 2, 2020 — ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Administration (FDA) has approved Rukobia (fostemsavir), 600…Original Article
FDA Approves Rukobia (fostemsavir) for HIV in Adults with Few Treatment Options Available
